# SMMT (Summit Therapeutics Inc.) - SEC EDGAR Financial Statements

> Summit Therapeutics Inc. reported $692.9M in total assets and a net loss of $832.7M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/SMMT
- Markdown: https://convexityos.com/fundamentals/SMMT.md
- SEC CIK: 0001599298
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001599298&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$1.09B | Operating profit |
| Net Income | FY 2025 | -$832.7M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.04 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$526.9M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $629.8M | Total debt: $19.98M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $0 | $0 | $705K | $1.81M | $860K | $743K | $57.09M |
| Research & Development | $537.7M | $150.8M | $59.47M | $52.00M | $85.35M | $53.27M | $39.81M | $52.00M |
| Total Operating Expenses | $1.09B | $226.0M | $609.6M | $87.21M | $109.0M | $73.36M | $51.09M | $74.31M |
| **Operating Income** | -$1.09B | -$226.0M | -$609.6M | -$72.09M | -$86.19M | -$53.19M | -$27.47M | $5.39M |
| **EBITDA** | -$1.09B | -$225.9M | -$609.5M | -$70.83M | -$84.84M | -$51.64M | -$26.18M | $6.90M |
| Interest Income | -- | -- | -- | $1.51M | $0 | $4.0K | $5.0K | $5.0K |
| Interest Expense | $0 | $8.69M | $16.46M | $4.40M | $242K | $255K | $291K | $620K |
| Income Before Tax | -$1.08B | -$221.3M | -$614.9M | -$78.78M | -$88.60M | -$52.91M | -$29.09M | $9.08M |
| Income Tax Expense | $0 | $0 | $0 | -- | $0 | -$213K | $36K | -$1.79M |
| **Net Income** | -$1.08B | -$221.3M | -$614.9M | -$78.78M | -$88.60M | -$52.70M | -$29.13M | $10.87M |
| Basic EPS | -$1.44 | -$0.31 | -$0.99 | -$0.41 | -$0.67 | -$0.53 | -$0.62 | $0.44 |
| **Diluted EPS** | -$1.44 | -$0.31 | -$0.99 | -$0.41 | -$0.67 | -$0.53 | -$0.62 | $0.44 |
| Basic Shares Outstanding | 747.7M | 718.5M | 619.6M | 193.3M | 131.7M | 99.3M | 46.9M | 24.5M |
| Diluted Shares Outstanding | 747.7M | 718.5M | 619.6M | 193.3M | 131.7M | 99.3M | 46.9M | 24.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $169.1M | $157.7M | $132.6M | $147.3M | $131.1M | $208.0M | $51.27M | $51.38M |
| Total Operating Expenses | $214.6M | $220.5M | $195.2M | $224.9M | $234.2M | $568.4M | $66.85M | $65.61M |
| **Operating Income** | -- | -- | -- | -- | -- | -- | -- | -$65.61M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$65.59M |
| Interest Expense | -- | -- | -- | $0 | $0 | $0 | $0 | $9.0K |
| **Net Income** | -$208.4M | -$215.7M | -$189.4M | -$219.2M | -$231.8M | -$565.7M | -$62.91M | -$61.20M |
| Basic EPS | -$0.26 | -$0.28 | -$0.24 | -- | -$0.31 | -$0.76 | -$0.09 | -- |
| **Diluted EPS** | -$0.26 | -$0.28 | -$0.24 | -- | -$0.31 | -$0.76 | -$0.09 | -- |
| Basic Shares Outstanding | 798.2M | 778.2M | 775.5M | -- | 743.4M | 742.6M | 738.1M | -- |
| Diluted Shares Outstanding | 798.2M | 778.2M | 775.5M | -- | 743.4M | 742.6M | 738.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $225.3M | $104.9M | $71.42M | $348.6M | $71.79M | $66.42M | $63.84M |
| Short-Term Investments | $488.2M | $307.5M | $114.8M | $0 | -- | -- | -- |
| **Cash & Short-Term Investments** | $713.4M | $412.3M | $186.2M | $348.6M | $71.79M | $66.42M | $63.84M |
| Accounts Receivable, Net | -- | -- | $0 | $349K | $1.46M | $331K | $541K |
| Other Current Assets | -- | -- | $181K | $486K | $1.20M | $1.52M | $1.40M |
| **Total Current Assets** | $720.3M | $423.8M | $189.7M | $656.7M | $97.31M | $87.67M | $79.63M |
| Property, Plant & Equipment, Net | $1.06M | $254K | $204K | $906K | $694K | $725K | $518K |
| Goodwill | $2.00M | $1.86M | $1.89M | $1.80M | $2.01M | $2.03M | $1.96M |
| Intangible Assets | -- | $0 | $0 | $0 | $10.40M | $11.52M | $13.12M |
| Other Non-Current Assets | $7.21M | $2.55M | $4.32M | $577K | $170K | $0 | -- |
| **Total Non-Current Assets** | $30.88M | $11.81M | $13.24M | $7.46M | $16.06M | $14.82M | $16.62M |
| **Total Assets** | $751.2M | $435.6M | $202.9M | $664.2M | $113.4M | $102.5M | $96.25M |
| Accounts Payable | $20.29M | $4.64M | $2.67M | $355K | $4.37M | $6.14M | $4.47M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $7.94M | $8.37M | $2.62M |
| Other Current Liabilities | $2.28M | $1.80M | $717K | $662K | $897K | $729K | $366K |
| **Total Current Liabilities** | $72.99M | $41.73M | $20.41M | $38.78M | $25.62M | $19.89M | $13.77M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $0 | $569K | $493K |
| Other Non-Current Liabilities | $1.83M | $1.63M | $1.56M | $1.43M | $2.78M | $2.51M | $2.70M |
| **Total Non-Current Liabilities** | $19.33M | $5.08M | $104.9M | $498.7M | $4.47M | $3.15M | $3.62M |
| **Total Liabilities** | $92.32M | $46.81M | $125.3M | $537.5M | $30.09M | $23.05M | $17.39M |
| **Total Debt (incl. Leases)** | $20.89M | $7.22M | $6.10M | $4.45M | $2.78M | $465K | $893K |
| Common Stock | $7.75M | $7.38M | $7.02M | $2.11M | $980K | $826K | $672K |
| Retained Earnings | -$2.29B | -$1.21B | -$993.3M | -$378.3M | -$299.5M | -$210.9M | -$158.2M |
| Accumulated Other Comp. Income | -$2.54M | -$2.29M | -$2.45M | -$1.89M | -$2.20M | -$3.79M | -$4.76M |
| **Total Stockholders' Equity** | $658.9M | $388.7M | $77.69M | $126.7M | $83.28M | $79.45M | $78.86M |
| Total Equity | $658.9M | $388.7M | $77.69M | $126.7M | $83.28M | $79.45M | $78.86M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $150.8M | $419.4M | $106.5M | $225.3M | $238.6M | $297.9M | $211.5M | $104.9M |
| Short-Term Investments | $479.0M | $271.3M | $492.2M | $488.2M | $0 | $0 | $149.8M | $307.5M |
| **Cash & Short-Term Investments** | $629.8M | $690.7M | $598.7M | $713.4M | $238.6M | $297.9M | $361.3M | $412.3M |
| **Total Current Assets** | $660.7M | $720.6M | $616.6M | $720.3M | $246.5M | $309.2M | $370.8M | $423.8M |
| Property, Plant & Equipment, Net | $2.53M | $1.78M | $1.66M | $1.06M | $810K | $690K | $652K | $254K |
| Goodwill | $1.98M | $1.97M | $1.97M | $2.00M | $2.00M | $2.04M | $1.92M | $1.86M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Assets | $8.96M | $8.45M | $8.23M | $7.21M | $7.03M | $6.52M | $4.14M | $2.55M |
| **Total Non-Current Assets** | $32.12M | $31.61M | $31.26M | $30.88M | $15.26M | $14.80M | $13.07M | $11.81M |
| **Total Assets** | $692.9M | $752.2M | $647.9M | $751.2M | $261.7M | $324.0M | $383.8M | $435.6M |
| Accounts Payable | $32.72M | $22.90M | $27.55M | $20.29M | $22.25M | $22.98M | $4.99M | $4.64M |
| Other Current Liabilities | $1.83M | $2.62M | $1.15M | $2.28M | $1.96M | $1.49M | $759K | $1.80M |
| **Total Current Liabilities** | $110.2M | $103.6M | $83.27M | $72.99M | $64.93M | $60.33M | $34.88M | $41.73M |
| Other Non-Current Liabilities | $1.81M | $1.80M | $1.80M | $1.83M | $1.83M | $1.84M | $1.71M | $1.63M |
| **Total Non-Current Liabilities** | $17.94M | $18.64M | $18.66M | $19.33M | $4.54M | $4.27M | $4.62M | $5.08M |
| **Total Liabilities** | $128.2M | $122.2M | $101.9M | $92.32M | $69.47M | $64.60M | $39.49M | $46.81M |
| **Total Debt (incl. Leases)** | $19.98M | $20.38M | $20.04M | $20.89M | $5.43M | $5.55M | $6.45M | $7.22M |
| Common Stock | $8.00M | $7.93M | $7.76M | $7.75M | $7.44M | $7.43M | $7.42M | $7.38M |
| Retained Earnings | -$2.91B | -$2.70B | -$2.48B | -$2.29B | -$2.07B | -$1.84B | -$1.28B | -$1.21B |
| Accumulated Other Comp. Income | -$2.70M | -$2.67M | -$2.63M | -$2.54M | -$2.71M | -$2.75M | -$2.56M | -$2.29M |
| **Total Stockholders' Equity** | $564.7M | $630.0M | $545.9M | $658.9M | $192.3M | $259.4M | $344.3M | $388.7M |
| Total Equity | $564.7M | $630.0M | $545.9M | $658.9M | $192.3M | $259.4M | $344.3M | $388.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.08B | -$221.3M | -$614.9M | -$78.78M | -$88.60M | -$52.70M | -$29.13M | $10.87M |
| Depreciation & Amortization | $146K | $89K | $198K | $1.26M | $1.35M | $1.55M | $1.29M | $1.51M |
| Stock-Based Compensation | $732.4M | $50.98M | $14.11M | $11.95M | $12.80M | $1.77M | $845K | $6.29M |
| Change in Receivables | -- | $0 | $359K | $975K | -$1.14M | $212K | $5.44M | -$2.47M |
| Change in Payables | $15.30M | $2.02M | $2.26M | -$4.13M | -$1.71M | $1.64M | -$1.31M | -$10K |
| **Operating Cash Flow** | -$322.9M | -$142.1M | -$76.76M | -$41.58M | -$72.59M | -$48.11M | -$20.76M | -$35.11M |
| Capital Expenditure | -$657K | -$139K | -$128K | -$624K | -$306K | -$421K | -$205K | -$157K |
| **Free Cash Flow** | -$323.6M | -$142.2M | -$76.89M | -$42.21M | -$72.89M | -$48.53M | -$20.96M | -$35.26M |
| **Investing Cash Flow** | -$174.3M | -$205.3M | -$587.8M | -$624K | -$306K | -$421K | -$341K | -$331K |
| Common Stock Issued | -- | -- | $104.7M | $100.0M | $75.00M | $50.00M | $50.41M | $46.08M |
| Dividends Paid | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Financing Cash Flow** | $617.5M | $381.2M | $86.51M | $620.2M | $77.92M | $50.55M | $49.51M | $44.51M |
| **Net Change in Cash** | $120.4M | $33.76M | -$577.2M | $576.8M | $5.37M | $2.58M | $28.60M | $6.75M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$208.4M | -$215.7M | -$189.4M | -$219.2M | -$231.8M | -$565.7M | -$62.91M | -$61.20M |
| Depreciation & Amortization | $85K | $46K | $44K | $42K | $42K | $37K | $25K | $22K |
| Stock-Based Compensation | $47.69M | $68.71M | $72.79M | $111.8M | $130.8M | $478.8M | $11.10M | $11.02M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Payables | $9.82M | -$3.91M | $6.80M | -$2.15M | -$839K | $17.93M | $356K | $1.53M |
| **Operating Cash Flow** | -$159.8M | -$141.1M | -$122.3M | -$101.9M | -$93.08M | -$66.74M | -$61.17M | -$48.67M |
| Capital Expenditure | -$396K | -$909K | -$245K | -$164K | -$71K | $0 | -$422K | -$14K |
| **Free Cash Flow** | -$160.2M | -$142.0M | -$122.5M | -$102.1M | -$93.15M | -$66.74M | -$61.59M | -$48.69M |
| **Investing Cash Flow** | -$204.2M | $222.9M | -$238K | -$485.2M | -$71K | $150.8M | $160.1M | $83.48M |
| **Financing Cash Flow** | $95.43M | $231.1M | $3.80M | $573.8M | $33.81M | $2.22M | $7.68M | -$23.61M |
| **Net Change in Cash** | -$268.6M | $312.9M | -$118.8M | -$13.29M | -$59.32M | $86.35M | $106.7M | $11.09M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -10225.4% | -4764.3% | -6185.2% | -3697.6% | 9.4% |
| **Net Profit Margin** | -- | -- | -- | -11174.8% | -4897.8% | -6127.6% | -3920.2% | 19.0% |
| Return on Equity (ROE) | -163.9% | -56.9% | -791.5% | -62.2% | -106.4% | -66.3% | -36.9% | -- |
| Return on Assets (ROA) | -143.7% | -50.8% | -303.0% | -11.9% | -78.2% | -51.4% | -30.3% | -- |
| Current Ratio | 9.87x | 10.15x | 9.30x | 16.93x | 3.80x | 4.41x | 5.78x | -- |
| Quick Ratio | 9.77x | 9.88x | 9.13x | 9.00x | 2.86x | 3.36x | 4.68x | -- |
| Debt to Equity | 0.03x | 0.02x | 0.08x | 0.04x | 0.03x | 0.01x | 0.01x | -- |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | -61.0% | +110.3% | +15.7% | -98.7% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -609.8% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -368.0% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -241.3% | -- |
| 5Y Revenue / Share Growth | -- | -100.0% | -100.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -323.5% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -147.5% | -135.9% | -220.9% | -163.9% | -479.4% | -287.6% | -69.9% | -56.9% |
| Return on Assets (ROA) | -120.2% | -113.8% | -186.2% | -143.7% | -352.1% | -230.2% | -62.7% | -50.8% |
| Current Ratio | 5.99x | 6.96x | 7.41x | 9.87x | 3.80x | 5.13x | 10.63x | 10.15x |
| Quick Ratio | 5.71x | 6.67x | 7.19x | 9.77x | 3.67x | 4.94x | 10.36x | 9.88x |
| Debt to Equity | 0.04x | 0.03x | 0.04x | 0.03x | 0.03x | 0.02x | 0.02x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
